Tag List


COVID-19 Research Update - Paediatrics Statistics

PIPSQC is pleased to share the "COVID-19 Research Update - Paediatrics Statistics" briefing prepared by Birmingham Health Partners.

In addition, PIPSQC is pleased to highlight the following pediatric critical care resources - including articles on multisystem inflammatory syndrome in children (MIS-C):
ACR - Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19
CCGCH - SARS-CoV-2 and the Emergence of Multisystem Inflammatory Syndrome in Children
COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach
EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry
U.K. lessons on the hyper-inflammatory shock syndrome in kids post-COVID-19; #PIMSTS / #MISC (slides)
Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children

Also of note are the following articles on the secondary effects of COVID-19 on children:
How Covid is making it tougher to tackle TB, AIDS, malaria and child health
Prioritising children's rights in the COVID-19 response
Transforming Pediatric Mental Health Services During a Pandemic
Urgency and Challenge of Opening K-12 Schools in the Fall of 2020
WHO - Countries failing to prevent violence against children, agencies warn
Who has been missed? Dramatic decrease in numbers of children seen for child protection assessments during the pandemic

Last but not least are the recent articles below:
Age-dependent effects in the transmission and control of COVID-19 epidemics
CDC - Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020
COVID-19 in children and transmission - tweetorial by @apsmunro
Impact of Disparities on Children's Health
Renal dysfunction in hospitalised children with COVID-19
The Lancet Child & Adolescent Health - July Issue - COVID-19 case series
WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients